Big Health

Big Health has built a digital cognitive behavioral therapy (CBT) platform addressing insomnia, generalized anxiety disorder (GAD), and depression. The company has established one of the most robust clinical evidence bases in digital therapeutics, with over 100 peer-reviewed publications and 26 randomized controlled trials demonstrating sustained outcomes at 6, 12, and 36-month follow-up across large patient cohorts. Big Health’s FDA-cleared prescription digital therapeutics (SleepioRx for insomnia and DaylightRx for anxiety) enable providers to deliver immediate access to first-line, evidence-based behavioral care at scale.